Varda
Private Company
Total funding raised: $51M
Overview
Varda is pioneering the orbital manufacturing and reentry sector, building the infrastructure to enable frequent, economical production and return of materials from low Earth orbit. Founded in 2020 and based in El Segundo, California, its core technology is the W-Series spacecraft, a self-sustaining satellite with a reentry capsule designed for microgravity research and production, with a strong focus on pharmaceutical crystallization. As a private, likely pre-revenue company, Varda targets both government hypersonic testing and biopharma clients, seeking to unlock new scientific and commercial opportunities in space.
Technology Platform
The W-Series spacecraft: a free-flying orbital satellite with integrated pharmaceutical processing equipment and a detachable, heat-shielded reentry capsule designed for frequent, economical return of materials from low Earth orbit.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Varda is a first-mover in dedicated commercial orbital manufacturing and return. Potential competitors include large aerospace primes (e.g., Northrop Grumman, Lockheed Martin) that could develop similar platforms, and other startups focusing on in-space manufacturing or space stations. Its unique integration of production and reliable reentry currently sets it apart.